TrialCNS drugs2020

Multiple-Ascending Dose Study in Healthy Subjects to Assess the Pharmacokinetics, Tolerability, and CYP3A4 Interaction Potential of the T-Type Calcium Channel Blocker ACT-709478, A Potential New Antiepileptic Drug.

Muriel Richard et al.PubMed ↗Publisher ↗

No numbers read from the abstract.